List of Radiopharmaceuticals/Radiotherapies Companies in Sweden - 2

Search through the full list with powerful filtering options

Company	About
Elekta P.O. Box 7593, Kungstensgatan 18, Stockholm, SE-103 93, SE	At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We've been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don't just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more.
OncoZenge AB Gustavslundsvägen 12, 5, Alvik, Stockholm County 16751, SE	OncoZenge is developing BupiZenge™, a lozenge based on the safe and effective non-opioid, long acting pain reliever bupivacaine. BupiZenge’s primary indication is oral mucositis and it has the potential to help millions of people with their oral pain caused by radiotherapy and chemotherapy.

Company

About

Elekta

P.O. Box 7593, Kungstensgatan 18, Stockholm, SE-103 93, SE

At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We've been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don't just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more.

OncoZenge AB

Gustavslundsvägen 12, 5, Alvik, Stockholm County 16751, SE

OncoZenge is developing BupiZenge™, a lozenge based on the safe and effective non-opioid, long acting pain reliever bupivacaine. BupiZenge’s primary indication is oral mucositis and it has the potential to help millions of people with their oral pain caused by radiotherapy and chemotherapy.